PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Pharma Failing to Address Corruption Risks

Pharm Exec's Brand of the Year 2016

Brexit and UK Pharma

Top Story

California and the Future of Rx Pricing

California is in the process of potentially establishing a new, disruptive healthcare policy that is proving to be very concerning to the American Rx industry, writes Tom Norton
... /Read more/

Considering changing product access vendors? Watch this brief video to learn an effective 4-point methodology to optimize your program transition by addressing data conversion, implementation planning, stakeholder communications, and technology.

Learn more

Regulatory

Promises and Pitfalls in Calculating Drug Value

There’s a stampede to relate prices to broader health benefits, but little consensus on how to do so, writes Jill Wechsler
... /Read more/

Breaking the Circle of Distrust with a Radical PLC Pricing Model
LIVE WEBCAST: Thursday, June 30, 2016 at 10 am EDT | 3 pm BST | 4 pm CEST

Free registration

Marketing

Snapchat for Fun and Profit?

Is Snapchat just a bit of fun for teenagers, or should pharma marketers be taking it seriously as a media platform? Peter Houston takes a look
... /Read more/

Best Practices for Integrating Biomarkers across the Drug Development Continuum
Live webinar: Wednesday, June 22, 2016 11 am EDT (8 am PST)

Forecast

Pharma and Biotech Financial Outlook: Hazy

Do recent trends in the pharma and biotech M&A and equity markets signal a temporary lull — or a permanent drop? Peter Young reports
... /Read more/

Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
On Demand

Learn more

Calendar

/ June 21–22: Patient Engagement Solutions Summit /

Philadelphia, PA.

/ June 22–23: Global Medical Information and Communications Summit /

Barcelona, Spain.

/ June 23–24: Bio/Pharma Product Forecasting Summit /

Philadelphia, PA.

/ August 15–17: 10^th Annual Forum on Transparency and Aggregate Spend /

Washington, DC.

/ September 15–16: Compliance Congress for Specialty Products /

Boston, MA

/ December 13–14: Life Sciences Trade and Channel Strategies /

Philadelphia, PA

Strategic considerations for clinical development programs in emerging biopharma companies
On Demand

Learn more

Understanding the Chronic Disease Patient Journey in Emerging Markets
On Demand

Learn more

Industry update

//Arsanis, Inc. (Waltham, MA) appointed Anthony Christopher (Chris) Stevens, M.D., as Chief Medical Officer.//Mallorca, Spain-based Laboratoris Sanifit S.L. announced the appointment of Preston S. Klassen, M.D., MHS, as Chief Medical Officer and the launch of its US Subsidiary Sanifit Inc., based in San Diego, CA.//ProNAi Therapeutics, Inc. (Vancouver, BC) appointed Dr. Christian Hassig as Senior Vice President, Research.//

Precision asset valuation Leveraging insights from clinical and market access big data
On Demand

Learn more

advertise with us / print subscribe / digital subscribe / visit pharmexec.com